BELLERI, Mirella
 Distribuzione geografica
Continente #
NA - Nord America 5.507
EU - Europa 2.945
AS - Asia 2.530
SA - Sud America 422
AF - Africa 72
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.498
Nazione #
US - Stati Uniti d'America 5.416
PL - Polonia 1.071
CN - Cina 844
SG - Singapore 821
UA - Ucraina 414
DE - Germania 384
BR - Brasile 344
HK - Hong Kong 260
IT - Italia 260
VN - Vietnam 202
FI - Finlandia 193
GB - Regno Unito 150
FR - Francia 124
RU - Federazione Russa 95
IN - India 92
BD - Bangladesh 82
TR - Turchia 77
IE - Irlanda 71
ES - Italia 52
CA - Canada 46
ID - Indonesia 28
SE - Svezia 28
ZA - Sudafrica 28
CZ - Repubblica Ceca 24
AR - Argentina 22
JP - Giappone 22
MX - Messico 19
AU - Australia 18
IQ - Iraq 16
NL - Olanda 16
CL - Cile 14
EC - Ecuador 13
AT - Austria 12
JM - Giamaica 11
VE - Venezuela 11
MA - Marocco 10
PH - Filippine 10
BE - Belgio 8
CO - Colombia 8
LT - Lituania 8
NG - Nigeria 8
PK - Pakistan 8
SA - Arabia Saudita 8
IR - Iran 7
KE - Kenya 7
TN - Tunisia 7
IL - Israele 6
HU - Ungheria 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CR - Costa Rica 4
JO - Giordania 4
KR - Corea 4
PE - Perù 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
KG - Kirghizistan 2
MU - Mauritius 2
NO - Norvegia 2
SV - El Salvador 2
TH - Thailandia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
MD - Moldavia 1
MM - Myanmar 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 11.495
Città #
Warsaw 1.070
Fairfield 581
Ashburn 556
Singapore 459
Woodbridge 383
Jacksonville 303
Houston 297
Hong Kong 258
San Jose 257
Ann Arbor 251
Cambridge 234
Chandler 220
Seattle 207
Beijing 194
Wilmington 184
Dallas 150
Princeton 127
The Dalles 123
Helsinki 118
Los Angeles 112
New York 107
Nanjing 105
Brescia 90
Dublin 71
Lauterbourg 65
Dearborn 64
Istanbul 64
Dong Ket 60
Munich 59
San Francisco 44
Ho Chi Minh City 43
Santa Clara 40
Madrid 39
Council Bluffs 38
São Paulo 36
Buffalo 35
Des Moines 34
Milan 33
Nanchang 32
Chicago 31
Hanoi 30
Shanghai 30
Lancaster 28
Orem 28
Jinan 27
Hebei 26
San Diego 26
Moscow 25
Changsha 23
Redondo Beach 23
Shenyang 23
London 22
Jakarta 20
Tianjin 20
Tokyo 20
Boardman 19
Phoenix 19
Rio de Janeiro 19
Turku 19
Brooklyn 18
Johannesburg 17
Brno 16
Washington 15
Atlanta 14
Boston 14
Chennai 14
Guangzhou 14
Jiaxing 14
Stockholm 14
Toronto 14
San Mateo 13
Lanzhou 11
Montreal 11
Ningbo 11
Nuremberg 11
Denver 10
Charlotte 9
Da Nang 9
Kunming 9
Paris 9
Zhengzhou 9
Brussels 8
Frankfurt am Main 8
Haikou 8
Hangzhou 8
Kingston 8
Las Vegas 8
Porto Alegre 8
Redwood City 8
Abuja 7
Dhaka 7
Mumbai 7
Poplar 7
Quito 7
Rome 7
Ardabil 6
Haiphong 6
Modena 6
Nairobi 6
Naples 6
Totale 8.033
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 378
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 357
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 323
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 316
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 285
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 285
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 282
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 278
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 267
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 214
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 213
Anti-angiogenic activity of the purine analog 6-thioguanine. 212
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 211
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 209
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 207
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 206
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 206
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 202
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 189
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 183
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 178
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 177
Beta-Galactosylceramidase deficiency: neurovascular implications 176
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 169
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 163
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 163
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 155
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 150
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 147
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 144
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. 142
A novel ex vivo murine retina angiogenesis (EMRA) assay 142
In vitro and ex vivo retina angiogenesis assays 140
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 139
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 137
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 137
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 135
Non competitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation 134
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 134
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 132
Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors 131
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 130
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 130
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 130
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 128
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 128
Role of inflammation in FGF2-driven angiogenesis 127
Undersulfated and glycol-split heparins endowed with antiangiogenic activity 126
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 126
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 125
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 125
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 124
Endothelial cell dysfunction in globoid cell leukodystrophy 122
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 121
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 117
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 115
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 114
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 111
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 108
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 107
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos 105
The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis 104
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 102
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 98
In Vitro and In Vivo Efficacy on Retinal Neo-Vascularization of an Innovative Broad-Range Anti-Angiogenic Synthetic Peptide (Uparant) 87
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process 84
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 80
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 77
Integrin -dependent antiangiogenic activity of resveratrol stereoisomers 74
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 72
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 71
β-Galactosylceramidase in cancer: more than a psychosine scavenger 48
Totale 11.690
Categoria #
all - tutte 49.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022621 26 134 15 15 12 25 36 30 26 105 53 144
2022/2023554 88 31 26 44 50 135 6 49 70 4 24 27
2023/2024719 47 41 106 26 42 107 33 21 136 34 19 107
2024/20251.358 18 11 5 193 130 142 117 65 153 82 264 178
2025/20263.213 311 366 291 443 347 220 457 117 181 260 143 77
2026/202716 16 0 0 0 0 0 0 0 0 0 0 0
Totale 11.690